رجوع
22
نطاق اليوم
KWD 32.56
KWD 34.78
نطاق 52 أسبوعًا
KWD 25.08
KWD 66.03
حجم التداول
8,473,462
متوسط 50 يوم / 200 يوم
KWD 41.89
/
KWD 37.93
الإغلاق السابق
KWD 34.40
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.4 | 0.4 |
| P/B | 0.8 | 2.9 |
| ROE % | -28.8 | 3.7 |
| Net Margin % | -3.4 | 3.8 |
| Rev Growth 5Y % | 11.5 | 10.0 |
| D/E | 0.9 | 0.2 |
النقاط الرئيسية
Revenue grew 11.51% annually over 5 years — strong growth
Earnings declined -301.91% over the past year
Generating 4.32B in free cash flow
PEG of 0.01 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.93%
Capital efficient — spends only 0.39% of revenue on capex
النمو
Revenue Growth (5Y)
11.51%
Revenue (1Y)19.44%
Earnings (1Y)-301.91%
FCF Growth (3Y)-22.82%
الجودة
Return on Equity
-28.79%
ROIC-14.75%
Net Margin-3.43%
Op. Margin-3.91%
الأمان
Debt / Equity
0.94
Current Ratio1.68
Interest Coverage-11.24
التقييم
P/E Ratio
-2.42
P/B Ratio0.81
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.44% | Revenue Growth (3Y) | 12.46% |
| Earnings Growth (1Y) | -301.91% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 194.78B | Net Income (TTM) | -6.67B |
| ROE | -28.79% | ROA | -8.59% |
| Gross Margin | 12.24% | Operating Margin | -3.91% |
| Net Margin | -3.43% | Free Cash Flow (TTM) | 4.32B |
| ROIC | -14.75% | FCF Growth (3Y) | -22.82% |
| Safety | |||
| Debt / Equity | 0.94 | Current Ratio | 1.68 |
| Interest Coverage | -11.24 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -2.42 | P/B Ratio | 0.81 |
| P/S Ratio | 0.08 | PEG Ratio | 0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 16.13B | Enterprise Value | 17.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 194.78B | 163.07B | 154.00B | 144.55B | 125.98B |
| Net Income | -6.67B | 3.31B | 2.70B | 1.20B | 1.35B |
| EPS (Diluted) | -13.62 | 6.31 | 4.95 | 2.07 | 2.28 |
| Gross Profit | 23.83B | 16.83B | 17.32B | 16.66B | 14.20B |
| Operating Income | -7.62B | 3.18B | 2.93B | 1.32B | 1.78B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 77.66B | 82.45B | 84.64B | 76.87B | 78.38B |
| Total Liabilities | 57.61B | 55.94B | 58.69B | 52.63B | 51.35B |
| Shareholders' Equity | 19.95B | 26.41B | 25.84B | 24.06B | 26.80B |
| Total Debt | 18.78B | 19.43B | 18.88B | 21.33B | 22.66B |
| Cash & Equivalents | 17.89B | 14.06B | 17.19B | 12.07B | 13.12B |
| Current Assets | 35.99B | 38.00B | 40.76B | 30.13B | 28.50B |
| Current Liabilities | 21.48B | 34.26B | 36.72B | 28.46B | 25.77B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#431 of 616
النشاط الأخير
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026